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A disulﬁde relay system (DRS) was recently identiﬁed in the yeast mitochondrial intermembrane space (IMS) that consists of two essen-
tial components: the sulfhydryl oxidase Erv1 and the redox-regulated import receptor Mia40. The DRS drives the import of cysteine-rich
proteins into the IMS via an oxidative folding mechanism. Erv1p is reoxidized within this system, transferring its electrons to molecular
oxygen through interactions with cytochrome c and cytochrome c oxidase (COX), thereby linking the DRS to the respiratory chain. The
role of the human Erv1 ortholog, GFER, in the DRS has been poorly explored. Using homozygosity mapping, we discovered that a muta-
tion in the GFER gene causes an infantile mitochondrial disorder. Three children born to healthy consanguineous parents presented
with progressivemyopathy and partial combined respiratory-chain deﬁciency, congenital cataract, sensorineural hearing loss, and devel-
opmental delay. The consequences of the mutation at the level of the patient’s muscle tissue and ﬁbroblasts were 1) a reduction in
complex I, II, and IV activity; 2) a lower cysteine-rich protein content; 3) abnormal ultrastructural morphology of the mitochondria,
with enlargement of the IMS space; and 4) accelerated time-dependent accumulation of multiple mtDNA deletions. Moreover, the
Saccharomyces cerevisiae erv1R182H mutant strain reproduced the complex IV activity defect and exhibited genetic instability of the
mtDNA and mitochondrial morphological defects. These ﬁndings shed light on the mechanisms of mitochondrial biogenesis, establish
the role of GFER in the human DRS, and promote an understanding of the pathogenesis of a new mitochondrial disease.Introduction
Classic mitochondrial disorders result from mutations in
the mitochondrial or nuclear DNA that disrupt mitochon-
drial respiratory function. These diseases typically have
brain and skeletal muscle manifestations and are, there-
fore, often referred to as mitochondrial encephalomyopa-
thies.1
Nuclear DNA mutations leading to mitochondrial
diseases have been described in genes encoding respira-
tory-chain subunits, oxidative phosphorylation assembly
factors, proteins involved in mtDNA maintenance, factors
related to mitochondrial protein synthesis, biosynthetic
enzymes, and proteins promoting mitochondrial biogen-
esis.2 Many of these proteins are synthesized in the cytosol
in the form of precursor proteins and posttranslationally
transported to the mitochondria in an unfolded state.
A subgroup of small cysteine-containing proteins, which
localize in the intermembrane space (IMS), requires the
cooperation of the translocase of the mitochondrial outer
membrane (TOM) complex with the Mia40-Erv1 disulﬁde
relay system (DRS) for intramitochondrial import.3 These
molecules include (1) proteins with a twin Cx3C motif
(two cysteines separated by three other amino acid resi-
dues), such as the entire family of small chaperone translo-con of the inner membrane (Tim) proteins, namely Tim8,
Tim9, Tim10,Tim12, andTim13 in Saccharomyces cerevisiae;
(2) proteins with a twin Cx9C motif, such as the copper
chaperone Cox17, which is required for the biogenesis of
cytochrome c oxidase (COX), and Cox19 and Cox23, two
additional molecules relevant to COX assembly; and (3)
other proteins with disulﬁde bonds, such Cox12, and the
copper chaperone for superoxide dismutase 1, Ccs1.4
Proven substrates of the DRS include many proteins
relevant to COX biogenesis, as well as many TIM chaper-
ones; therefore, a defect in this pathway is likely to result
in pleiotropic effects due to a defective IMS and matrix
import of proteins relevant to complex IV biogenesis
and a number of yet uncharacterized mitochondrial func-
tions.
We ascertained an inbred Moroccan family with three
siblingsaffectedbycongenital cataract,progressivemuscular
hypotonia, sensorineural hearing loss, and developmental
delay. Linkage analysis, followedby the sequencingof candi-
date genes, revealed the presence of a missense mutation in
GFER (growth factor, augmenter of liver regeneration ERV1
homolog, S. cerevisiae, MIM 600924) that affects the protein
content of the IMS, including some proteins involved in
COX biogenesis, and leads to a progressive mitochondrial
myopathy.1Dino Ferrari Centre, Department of Neurological Sciences, University of Milan, 20122 Milan, Italy; 2Fondazione I.R.C.C.S. Ospedale Maggiore Policlinico,
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Subjects and Methods
Subjects
Written informed consent was obtained from the parents of the
patients, and investigations were carried out according to the
guidelines of the Ethical Committee of ‘‘Fondazione I.R.C.C.S.
Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena’’ in
Milan, Italy in agreement with Italian and European Union laws.
Subjects II-2, II-4, and II-5 were born of consanguineous
Moroccan parents after normal pregnancies. There was no neuro-
logical disease or congenital cataract in the family. All patients
were born at term, and their birth weights were appropriate
for their ages. All patients presented with congenital cataract,
muscular hypotonia, sensorineural hearing loss, and develop-
mental delay.
Patient II-2 presented with axial hypotonia and congenital cata-
ract during the ﬁrst month of life. At the age of one year, II-2
underwent surgery for the cataract with partial beneﬁt. The
patient also had a psychomotor delay with the ability to walk at
2 years and to speak at 3 years; he attended basic school and
needed tutorial help for difﬁculties in his studies as a result of
a progressive visual deﬁcit. At 11 years old, after several surgeries,
the patient suffered from retinal detachment and severe visual
impairment. Since the age of 12 years, II-2 has presented with
severe progressive hearing loss and bilateral ptosis. At the age of
17 years, neurological examination revealed generalized muscular
hypotonia and hypotrophy, especially in the lower limbs, he could
walk only with help, he was unable to ﬁx his gaze, and rotatory
nystagmus was noted. Proximal and distal muscle strength was
normal. The upper- and lower-limb deep-tendon reﬂexes were
weak or absent. No defects of the deep or superﬁcial sensations
were noted. Audiological examination showed a severe bilateral
hearing deﬁciency. The ECG and echocardiography were normal.
Blood analysis revealed hypoferritinemia (25 ng/ml, range 30–
270), hyperamylasemia (351 U/l, range 0–195), and hyperCKemia
(195 U/l). Serum lactate was elevated to 24.9 mg/dl (normal range
4.5–19). A muscle biopsy of the right brachial biceps was per-
formed. An MRI of the brain performed at that time showed
a thin corpus callosum; the signal from other telencephalic struc-
tures and the ventricular size was normal.
Patient II-4 presented with congenital cataract and progressive
axial hypotonia. When the patient was 7 years of age, a neurolog-
ical examination revealed unilateral ptosis, slight sensorineural
hearing loss, diffuse muscle hypotrophy, and hypotonia. Blood
analysis revealed low serum ferritin levels, hyperamylasemia, and
hyperCKemia. The patient’s serum lactate was high (34.2 mg/dl).
A muscle biopsy of the right brachial biceps was performed.
Patient II-5 had congenital cataract, and a neurological exami-
nation performed when the patient was 3 years of age revealed
slight axial hypotonia. No muscle biopsy was performed.
Skeletal Muscle Biopsy and Ultrastructural Analysis
After written informed consent was obtained, biopsies of the left
biceps muscle were performed in patients II-2 and II-4 according
to a protocol approved by the Institutional Review Board of the
Fondazione I.R.C.C.S, Ospedale Maggiore Policlinico, Mangiagalli
e Regina Elena inMilan, Italy. Ten-micron cryostatic cross sections
were processed according to standard histological and histochem-
ical techniques.5 Mitochondrial enzymatic activity was demon-
strated by COX and a double reaction for COX and succinate
dehydrogenase (SDH).6 A sequential demonstration of COX andThe AmSDH activities was performed on 10 mm slices of the cryostat
sections from the muscle biopsies. The ultrastructural analysis
was performed with a TEM Philips CM-100 microscope as previ-
ously described.7 The yeast ultrastructural analysis was performed
as previously described.8
mtDNA Analysis
PCR assay for detecting multiple deletions used two primers
(forward 7440–7465 and reverse complement 16135–16110) and
the following ampliﬁcation protocol: an initial denaturation at
94C for 2 min, followed by 25 cycles (94C for 30 s, 55C for 30 s,
and 68C for 90 s) and a ﬁnal extension for 2 min at 72C (Plat-
inum HiFi Taq Polymerase by Invitrogen, Carlsbad, CA). For the
identiﬁcation of deletion breakpoints, PCR products were subcl-
oned in TOPO-TA cloning vector (Invitrogen) and sequenced on
an ABI Prism 3100 Genetic Analyzer via Big Dye Terminator 3.1
protocol (Applied Biosystems, Foster City, CA).
Genetic Studies and Linkage Analysis
Blood-derived DNA samples from all family members were geno-
typed via the Affymetrix GeneChip HumanMapping 50K Xba240
Array according to protocols provided by the manufacturer (Affy-
metrix, Santa Clara, CA). Up to 50,000 SNPs were investigated,
with an average spacing of approximately 12 kb. Genotypes were
called with the GeneChip DNA Analysis Software (GDAS v.3).
Mendelian errors were evaluated by Pedcheck and removed from
further analysis. A parametric linkage analysis was performed
with ALLEGRO software. Haplotypes reconstructed by ALLEGRO
were presented graphically by HaploPainter. All data handling
was performed with the graphical user interface Easy Linkage.9
A sequence analysis of genes previously reported to be mutated
in patients with multiple deletions in mtDNA (POLG, POLG2,
ANT1, PEO1) was performed as described above. Results were
normal in affected individuals. The coding exons of candidate
genes belonging to the identiﬁed region were ampliﬁed via oligo-
nucleotide primers, which are available upon request.
We ampliﬁed the exons and intronic boundaries of GFER, using
speciﬁc primers (Table S1, available online) and performing an
initial denaturation at 95C for 2 min, followed by 35 cycles of
94C for 30 s, 59C for 30 s, and 72C for 40 s, and a ﬁnal exten-
sion at 72C for 5 min (Invitrogen Platinum Taq Polymerase
plus 10% DMSO and 5 M Betaine). After puriﬁcation, the PCR
products were sequenced as described above.
Healthy control subjects were screened for the identiﬁed muta-
tion in the GFER gene via sequence analysis.
Cell Cultures and Transfection Procedures
Cell cultures were established from the patients’ skin and muscle
biopsies as previously described.10 The control muscle biopsies
and cell cultures used in this study were derived from the Telethon
Genetic Biobanks Network GTB07001E, Department of Neurolog-
ical Sciences, University of Milan, Italy). Primary myoblasts were
cultured in skeletal muscle cell growth medium (PromoCell
GmbH, Heidelberg, Germany) at 37C in 5% CO2. Primary ﬁbro-
blasts were cultured in DMEM medium (Invitrogen) with 15%
FBS at 37C in 5% CO2. For determination of the rate of primary
cell proliferation, themean population doubling (MPD) was calcu-
lated as previously described.11 A comparison of quantitative
parameters between groups was performed with the Mann-Whit-
ney U test. A p value below 0.05 was considered signiﬁcant.erican Journal of Human Genetics 84, 594–604, May 15, 2009 595
Wild-type GFER cDNAwas retrotranscribed with the use of total
RNA extracted from control muscle tissue and cloned into the
pAcGFP1-N2 expression vector (Clontech Laboratories,Mountain-
view, CA). The recombinant vector was propagated in XL-10 Gold
UltracompetentE. coli cells (Stratagene, La Jolla,CA). Plasmid trans-
fection was carried out in patient and control primary ﬁbroblasts
via electroporationwith the HumanDermal Fibroblast kit (Amaxa,
Gaithersburg, MD).
We evaluated GFER by using the HEK293 cell line, which was
stably transfected with two vectors overexpressing wild-type and
mutated GFER cDNA. Transfections were carried out as described
above, and selection was performed through the addition of
G418 to the culture medium (500 mg/ml). Rates of transfection
and the expression of GFP-tagged GFER were evaluated by ﬂuores-
cence microscopy and FACS analysis (data not shown).
Biochemical Assays
The speciﬁc activities of individual respiratory-chain complexes
were measured in cells and muscle homogenates.12 Proteins
were extracted frommuscle tissue aftermotor-driven homogeniza-
tion and from cells after sonication in resuspension buffer. The
protein concentration was measured via the Lowry method. The
speciﬁc activity of each complex was normalized to that of citrate
synthase.
GFER mRNA Quantiﬁcation
Total RNA from the probands’ tissues was reverse transcribed (First
Strand cDNA Synthesis Kit, GE Healthcare) and quantiﬁed by
quantitative PCR via the DDCt method on a 7500 Real Time PCR
System (Software 2.01, Applied Biosystems, Foster City, CA). The
GFER mRNA was evaluated with the Taqman gene expression
assay (Hs00193365_m1), and GAPDH was used as the control
housekeeping gene (Hs99999905_m1). The expression of GFER
was also quantiﬁed in several control human tissues contained
in Human Total Master Panel II (Clontech Laboratories, Mountain
view, CA). The rates of GFER expression were also evaluated in
transfected HEK293 cell lines. Overexpression (>50-fold change)
was observed in transfected HEK293 cells, and comparable levels
were observed in cells containing wild-type or mutated GFER
expression vectors (data not shown).
Immunocytochemistry
Myoblasts, ﬁbroblasts, and HEK293 mitochondria were stained
with MitoTracker Red (Invitrogen) in fresh culture medium for
30 min at 37C. For double immunostaining, cells were ﬁxed
with 4% formaldehyde for 15 min at 37C. After rinsing with PBS
and preincubation with 0.25% Triton X-100 in PBS, the cultures
were incubated with the primary antibodies at 4C. The following
proteins were evaluated: GFER, TIMM13, and COX17 with rabbit
polyclonal antibodies (Proteintech Group, Manchester, UK),
COX6B1 with mouse monoclonal antibody (Molecular Probes,
Invitrogen). After repeated rinses with PBS, the primary unconju-
gated antibodies were further incubated with R-Phycoerythrin
(RPE) or TRITC-conjugated secondary antibodies (1:100; DAKO)
in PBS for 2 hr in the dark at room temperature, then rinsed with
PBS and coverslipped.
Subcellular Fractionation
Mitochondria were puriﬁed through modiﬁcation of a published
protocol.13 HEK293 cells (roughly 10 million cells) were collected
and passed 40 times through a 27-gauge needle in a buffer contain-596 The American Journal of Human Genetics 84, 594–604, May 15ing 250 mM sucrose, 10 mM Tris, and 0.1 mM EGTA (pH 7.4) and
centrifuged at 6303 g for 10min. The supernatantwas then centri-
fuged at 80003 g for 15min for isolation of a crudemitochondrial
pellet. The supernatant was subjected to further centrifugation at
48,000 3 g for 1 hr 30 min, and the ﬁnal supernatant was desig-
nated the cytosolic fraction. The crude mitochondrial pellet was
washed once with the extraction buffer and sedimented at 6303 g
for 10 min. The remaining supernatant was further centrifuged at
8000 g for 15min, and the residual pellet was designated themito-
chondrial fraction.
Protein Blot Analyses
Mitochondrial fractions derived from HEK293 cells were analyzed
by SDS-PAGE according to Laemmli without the addition of
reducing agents in the sample buffer. For reducing conditions,
dithiothreitol (DTT) at a ﬁnal concentration of 15 mM was added
during sample preparation, whereas nonreducing analyses were
completely DTT free.
The polyacrylamide gels (11%) were run for 2 hr and blotted.
The GFER protein was assayed with a commercial polyclonal anti-
body developed in rabbit (Proteintech Group). After incubation
with a peroxidase-conjugated secondary antibody, the GFER signal
was detected with ECL-detection reagents (Amersham). The
HSP60 (Santa Cruz Biotechnology) and COX4 (Molecular Probes)
proteins were used as a normalization control of the mitochon-
drial fractions.
Yeast Model
Construction of Yeast Strains
Yeast strains were derived from the diploid DWW, obtained from
the cross between strains W303-1A (Mata ade2-1 leu2-3, 112
ura3-1 trp1-1 his3-11, 15 can1-100) and W303-1B (Mata ade2-1
leu2-3, 112 ura3-1 trp1-1 his3-11, 15 can1-100). Being that ERV1
is an essential gene, the construction of a null erv1 strain carrying
either ERV1 or the erv1R182H allele required a particular procedure.
One copy of the ERV1 ORF was deleted in the diploid DWW and
substituted with the Kanr marker, resulting in the heterozygous
diploid DMT1 (ERV1/Derv1) strain. The ERV1 gene, ampliﬁed by
PCR from the W303-1B strain and cloned into the centromeric
pFL38 vector containing the auxotrophic marker URA3, was
then introduced into DMT1. By sporulation and tetrad analysis,
the haploid DMT1-4C/38E strain (Derv1, carrying a plasmid-borne
ERV1 wild-type copy) was then obtained. This strain was trans-
formed with the erv1R182H allele, which was produced by site-
directed mutagenesis, via the overlap-extension technique14 and
cloned into the centromeric pFL39 vector containing the auxotro-
phic marker TRP1. The preferred yeast codon encoding histidine
(CAT) was used in the sequence of the mutagenic oligonucleo-
tides, maximizing the expression of the mutant allele. It was
then possible to isolate the DMT1/39e strain (Derv1, carrying the
plasmid-borne erv1R182H mutant allele) devoid of pFL38ERV1
and completely isogenic with the DMT1-4C/38E strain by plasmid
shufﬂing in the presence of 5-ﬂuoro orotic acid (5FOA, SIGMA),
which is toxic to URA3 strains but not to the ura3 mutants.
Miscellaneous Yeast Methods
Cells were cultured in 0.67% yeast nitrogen base (YNB) without
amino acids (Difco), supplemented with appropriate amino acids
and bases for auxotrophy to a ﬁnal concentration of 40 mg/ml.
Various carbon sources were added at 2% (w/v).
Cytochrome spectra were determined as described previously.15
The spectrum proﬁle was recorded in cells grown at 28C, so that, 2009
the required biomass could be obtained, then shifted to 37C for
15hr. Spectrophotometricmeasurements ofCOXactivitywereper-
formed for 120 s at 30C in isolatedmitochondria after the decrease
Figure 1. Histochemical and Ultrastructural Analysis of
Probands’ Skeletal Muscle
(A–D) COX histochemistry reveals the presence of several COX-defi-
cient fibers in probands II-2 and II-4 (A and B). Double staining for
COX/SDH. Scattered fibers with increased SDH staining, indicative of
mitochondrial proliferation, are present in patient II-2. A COX defi-
ciency is confirmed in both patient II-2 and patient II-4. (C and D)
Insets within panels (A) and (C) represent the normal controls.
(E and F) Electron microscopy shows several mitochondria with
thickened cristae; many mitochondria are also present with large
vacuolization in (E).
Scale bars represent 25 mm (A–D), 700 nm (E), or 250 nm (F).of absorbance at 550 nm as a result of cytochrome c oxidation.16
The speciﬁc activity was normalized to that of citrate synthase.
For a respiratory-deﬁcient diagnosis (petite colonies), cells from
cultures grown for 15 generations at 37C in YNB supplemented
with glucose were plated onto solid YNB medium containing
2% ethanol and 0.3% glucose and maintained for 5 days at
28C. Amit-complementation-based analysis of mtDNAwas per-
formed on respiratory-deﬁcient colonies as previously described.17
Results
Morphological and Biochemical Studies
The muscle biopsies from subjects II-2 and II-4 exhibited
scattered COX-negative ﬁbers (Figures 1A–1D). Biochem-
ical studies revealed a consistent moderate reduction
(30%–50% of normal mean values) of complex IV activity
in multiple tissues from both probands (Table 1).
Interestingly, patient II-2 displayed a multicomplex
alteration, including a complex I and II defect in both
muscle and myoblasts, whereas an analysis of patient
II-4’s ﬁbroblasts revealed only reduced complex IV
activity.
The ultrastructural analysis of patient II-20s muscle tissue
showed striking mitochondrial structural abnormalities. In
addition to being abnormally enlarged, these organelles
exhibited increased electron density and thickened cristae.
In a subset of mitochondria, large electron-dense vacuoli-
zations were observed, probably representing an abnormal
IMS (Figures 1E and 1F). Multiple mtDNA deletions were
found by PCR analysis of muscle from patient II-2 (not
shown).
Linkage Analysis and Mutation Screening
We performed a genome-wide linkage analysis in all family
members, using the Affymetrix GeneChip SNP array. A
single region of autozygosity on chromosome 16p13.3
(LOD score 2.657) was identiﬁed (Figure 2A). This region
(0–12.1 Mb), conﬁrmed by microsatellite analysis (Fig-
ure 2B), encompasses 271 genes. Candidate genes wereTable 1. Activities of the Respiratory-Chain Complex
CI/CS CII/CS CIþIII/CS CIIþIII/CS CIV/CS
Muscle
Proband II-2 6.6 (46.5%) 7.2 (62.1%) 16.4 (47.4%) 8.0 (65.0%) 20.1 (44.8%)
Normal (n ¼ 38) 14.25 2.6 11.65 1.8 34.65 7.8 12.35 2.7 44.85 5.6
Fibroblasts
Proband II-4 54.8 6.1 311.3 4.9 31.7 (70.0%)
Normal (n ¼ 16) 68.75 22.7 6.85 1.2 225.785 71 4.915 1.2 44.85 4.7
Myoblasts
Proband II-2 33.8 (66.4%) 4.4 (46.8%) 255.6 5.4 27.8 (47.3%)
Normal (n ¼ 12) 50.95 8.5 9.45 2.2 209.45 27.1 6.05 1.2 58.85 7.4
Mean values (5 1 SD) of the activities of the respiratory-chain complex are normalized to citrate synthase (CS). Activities are expressed as nM/min/mg
protein. Activities reduced by at least 30% of the normal mean values are shown in bold. n¼ number of controls. Biochemical determinations on probands’
tissues were performed in triplicate.
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Figure 2. Linkage Analysis, Expression Studies, and Mutation Analysis
(A) Multipoint linkage analysis of the genome-wide scan with the Affymetrix GeneChip Human Mapping 50K Array Xba240.
(B) Family pedigree and haplotype analysis of the GFER locus. Affected individuals are indicated by black symbols.
(C) Quantitative RT-PCR of GFER expression in 20 human control tissues. GAPDH was used as the control housekeeping gene. The thymus
mRNA level was used for normalization of the expression data. All determinations have been performed in replicates (n ¼ 6).
(D) Quantitative RT-PCR of GFER expression in muscle and fibroblasts from patients and controls. Results are presented as mean5 SD.
(E) CLUSTALW multiple-alignment sequence of the GFER region containing the mutated residue in our family. The electropherogram of the
c.581 G/A mutation in exon 3 of GFER, resulting in a p.R194H substitution, is shown above.prioritized according to the likelihood score of mitochon-
drial localization, as implemented in the ‘‘Maestro’’ data
set.18
We sequenced the exons and ﬂanking intronic regions of
ten genes encoding known or putative mitochondrial
proteins:GFER, FAHD1,NDUFB10,NUBP2,DNAJA3,NME4,
Magmas, NTHL1, TRAP1, and MPG. Sequencing of GFER
revealed a c.581G/Ahomozygousmutation in all affected
individuals (Figure S1), which results in the p.R194H substi-
tution. Thismutationwas absent in 380 samples fromunre-598 The American Journal of Human Genetics 84, 594–604, May 15lated European individuals and 183 samples fromunrelated
Arab individuals (156 Moroccan).
Expression Analysis
The GFER gene is ubiquitously expressed (Figure 2C) in
human tissues, the highest expression in the testis and liver
and low expression in muscle. Quantitative RT-PCR anal-
ysis of the muscle RNA from patient II-2, ﬁbroblast RNA
from patient II-4, and relative controls showed no signiﬁ-
cant difference in the GFER expression level (Figure 2D)., 2009
Figure 3. Western Blot Analysis of Overexpressed GFER, Immunocytochemical Analysis of Endogenous GFER in Patient Myoblasts,
and Functional Rescue in Patient Fibroblasts
(A) HEK293 cells were stably transfected with vector overexpressing GFERwild-type and GFERR194H cDNA. Immunoblot analysis showed
a reduction of GFERR194H in mitochondrial fractions under both reducing (DTT 15 mM) and nonreducing conditions. COX4 and HSP60
were used for normalization.
(B) Antibodies against human GFER showed specific GFER colocalization with MitoTracker and DAPI in control myoblasts, whereas immu-
nofluorescence was almost absent in the cytoplasm. Instead, primary myoblasts from patient II-2 showed a reduced punctuate mitochon-
drial fluorescence compared to control cells with more diffuse cytoplasmic staining. Scale bar represents 40 mm.
(C) Biochemical functional rescue in proband II-4 fibroblasts that were transfected with GFERwild-type cDNA. The analysis of COX activity
(normalized to citrate synthase [CS]) shows a restoration of mitochondrial cytochrome c oxidation (complex IV). Results are presented as
mean of triplicate determinations 5 SD.GFER Analysis in Probands and Transfected
HEK293 Cells
To testwhether thep.R194Hmutation (Figure 2E) can affect
protein stability and dimer formation, we carried out
a immunoblot analysis of HEK293 mitochondrial fractions
overexpressing either wild-type or mutant GFER. Immuno-
blots using the antibody against GFER under reducing and
nonreducing conditions showed a reduction of both the
GFERR194H monomer and the dimer as compared to the
wild-type protein (Figure 3A). Quantitative RT-PCR found
no signiﬁcant differences at the transcriptional level in
the total RNA from HEK293 transfected with the wild-
type or mutant constructs (data not shown). These results
suggest that GFERR194H is less stable in the IMS. Alterna-The Amtively, being that ERV1 is a substrate of the Mia40-Erv1
import pathway,19 the GFERR194H protein could be either
less efﬁciently imported into or less retained by the IMS.
Further study will address this issue.
To test whether the p.R194H mutation affects GFER
protein localization, we performed an immunocytochem-
ical analysis of myoblasts from patient II-2 and controls.
Throughout our experiments, primary cells from patients
presented with a lower rate of proliferation compared
to control cells (myoblast MPD II-2, 135 2; control MPD,
28 5 3; p < 0.00001). In control myoblasts, the GFER-
speciﬁc immunoﬂuorescence pattern colocalized with that
ofMitoTracker andDAPI andwas almost absent in the cyto-
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punctuatemitochondrial ﬂuorescence compared to control
cells, with more diffuse cytoplasmic staining (Figure 3B).
Complementation Studies in Human Cells
As previously mentioned, the ﬁbroblasts from patient II-4
exhibited a COX deﬁciency, whereas other respiratory-
chain activities were normal. To evaluate whether the
mutated GFER gene was the cause of the complex IV deﬁ-
ciency, we transiently transfected primary ﬁbroblasts
from patient II-4 and several controls with GFERwt cDNA.
Biochemical analysis revealed a 30% increase in COX
activity in GFERwt-transfected patient ﬁbroblasts, normal-
ized to the citrate synthase activity, whereas COX activity
remained unchanged in cells transfected with empty
vector (Figure 3C). These results demonstrate that the
p.R194H mutation is associated with the functional COX
defect found in our patients, and they also clearly establish
the key role of GFER in complex IV activity in humans.
Analysis of IMS Proteins
To further characterize the role of GFERR194H in mitochon-
drial biogenesis, we carried out an immunocytochemical
analysis of two known DRS substrates, COX17 and
TIMM13, as well as COX6B1, in ﬁbroblasts from patient
II-4. Confocal analysis revealed reduced colocalization of
COX17, TIMM13, and COX6B1 immunostaining with
MitoTracker compared to the colocalization signal observed
in control cells from healthy donors (Figure 4).
Yeast Model
In order to validate the pathogenicity of the human muta-
tion, we set up a recombinant system in S. cerevisiae. The
R194H mutation was introduced into the fully conserved
R182 position of ScERV1, and this mutant allele was
expressed in the null erv1 strain. The resulting erv1R182H
mutant strain (Derv1//erv1R182H) grew on both glucose and
oxidative substrates, but it displayed a thermosensitive
phenotype. Growth was delayed on solid medium
(Figure 5A) and blocked in liquid medium at 37C (data
not shown). Measurement of the mitochondrial cyto-
chrome content is an index of the structural integrity
of the respiratory-chain complexes. The strain carrying
erv1R182H displayed a signiﬁcant reduction in cytochrome
aa3 but not cytochromes b and c (Figure 5B). Indeed, in
mitochondria isolated from the erv1R182H mutant, COX
activity was reduced by 45% (Figure 5C).
Erv1p is not known to import proteins necessary for the
mtDNA replication machinery. Therefore, erv1 mutations
should not increase mtDNA mutability. However, Erv1p
contributes, either directly or indirectly, to the assembly
of components of the inner mitochondrial membrane,
where the mtDNA is replicated. To evaluate whether the
erv1R182H mutation is associated with mtDNA instability,
wemeasured the frequency of petitemutants in the haploid
Derv1 strain carrying either the wild-type or the erv1R182H
allele. The mtDNA instability in S. cerevisiae is associated
with the increased segregation of respiratory-deﬁcient petite600 The American Journal of Human Genetics 84, 594–604, May 15mutants. In the presence of the erv1R182H allele, the petite
frequency was approximately twice that determined in the
Derv1 strain transformed with ERV1 (Figure 5D), suggesting
a role for Erv1p in maintaining the integrity of mtDNA.
Petite mutants can be either rho (that is, cells in which
the mtDNA is partially deleted) or rhoo (that is, cells in
which themtDNAis completely lost). Toevaluate thenature
of the petitemutations (rho versus rhoo), we crossed petite
clones with mit strains, each harboring a different point
mutation in three genes encoding respiratory proteins.
Figure 4. Confocal Immunocytochemical Analysis of IMS
Proteins in Patient Fibroblasts
Immunocytochemistry of patient and control fibroblasts, using
antibodies against TIMM13, COX17, and COX6B1. Confocal analysis
revealed reduced colocalization of COX17, TIMM13, and COX6B1
immunostaining with MitoTracker compared to the colocalization
signal observed in control cells from healthy donors. Scale bars
represent 40 mm (A–F) or 20 mm (G–R)., 2009
When rhomutants are crossed with a mitmutant, respi-
ratory-competent rhoþ cells are produced by recombina-
tion, provided that the mit point mutation maps to
a region conserved in the rho mtDNA. Contrariwise, rhoo
mutants, which are completely devoid of mtDNA, are
unable to produce rhoþ cells. By this analysis, it is possible
to establish whether the erv1R182Hmutation causes mtDNA
deletion or depletion. This complementation test revealed
that approximately 70% of the petite clones resulted in
rho, in the presence of both erv1R182H and ERV1 alleles
(data not shown), indicating that the mutation determines
an increase in mtDNA mutability not associated with
increased mtDNA depletion, which would result in an
increase in rhoo mutants.
The ultrastructural analysis of the erv1R182H mutant
showed clusters of mitochondria with simpliﬁed or absent
cristae (Figure S2).
Discussion
We describe three patients who presented with progressive
myopathy, congenital cataract, sensorineural hearing loss,
and developmental delay. In the probands’ muscle tissue,
the activities of respiratory-chain complexes I, II, and IV
were decreased by 50%, 33%, and 50%, respectively,
compared to mean control values. Using homozygosity
mapping, we identiﬁed a missense mutation in the GFER
gene affecting a conserved residue, and it was associated
Figure 5. Yeast Model
(A) Phenotypic analysis of the DMT1-4C
strain (Derv1) carrying either ERV1 or the
erv1R182H allele. The growth phenotype was
that observed at 37C. Equal amounts of
serial dilutions of cells from exponentially
grown cultures were spotted onto YNB
medium supplemented with 2% glucose.
(B) Cytochrome spectra of cells grown on
YNB medium supplementedwith 2% glucose
at 28C and then shifted to 37C overnight
(A denotes absorbance).
(C) COX activity measured in the ERV1 and
erv1R182H strains.
(D) Petite frequency of Derv1 strain trans-
formedwithwild-type ERV1and theerv1R182H
mutant allele. COX activity and petite
frequency determinations were performed
in triplicate. The error bars represent SD.
with altered protein localization in
patient myoblasts and a reduction in
the protein level in transfected
HEK293 mitochondrial fractions.
Human GFER belongs to the ERV1/
ALR protein family, members of
which are found in lower and higher
eukaryotes.20 The GFER gene codes
for two distinct isoforms that are
probably synthesized from the same mRNA with the use
of different initiation codons. The long isoform (205 aa,
23 kDa) is located mainly in the mitochondrial IMS, and
it exists under nonreducing and nondenaturing condi-
tions as a homodimer and a heterodimer. The shorter iso-
form (125 aa, 15 kDa), which lacks 80 amino acids at its
N terminus, is present predominantly in the nucleus.21
The yeast ortholog Erv1p is the key protein of the mito-
chondrial DRS. Through its ﬂavin-linked sulfhydryl
oxidase activity, Erv1p oxidizes the disulﬁde carrier protein
Mia40, which in turn transfers a disulﬁde to the newly
synthesized small cysteine-containing proteins arriving
in the IMS22–24 (Figure 6). Erv1p is then reoxidized, trans-
ferring its electrons to molecular oxygen via interactions
with cytochrome c and COX, linking the DRS to respira-
tory-chain activity.25 Erv1p depletion prevents the import
of those essential proteins and leads to mtDNA aberrations
and abnormal mitochondrial morphology.26
The role of mammalian GFER in the mitochondrial DRS
has been poorly explored. The rat and human GFER
proteins act as sulfhydryl oxidases27 and probably play
a role similar to that of yeast Erv1p.
Using confocal immunocytochemistry and immunoblot
analysis, we showed that GFERR194H is less stable than the
wild-type protein within the mitochondria. This relative
mitochondrial depletion may disturb the mitochondrial
import of several DRS substrates. We showed by confocal
analysis that primaryﬁbroblasts fromanaffected individualThe American Journal of Human Genetics 84, 594–604, May 15, 2009 601
Figure 6. The Mitochondrial Disulfide Relay System
Schematic representation of the mitochondrial DRS, which mediates the import of cysteine-rich substrates into the IMS by an oxidative
trapping mechanism. Mia40 performs the oxidation of these proteins and is reoxidized by Erv1/GFER in a disulfide-transfer reaction. For
Erv1 to be recycled into its oxidized form, electrons are transferred to cytochrome c, connecting the DRS to the electron-transport chain of
the mitochondria.probably have a reduced mitochondrial signal for COX17
and TIMM13, which are known DRS substrates in yeast,3
as well as COX6B1, a protein with a twin Cx9C motif. A
partial mitochondrial depletion of COX17 and COX6B1
may result in COX-defective biogenesis. Indeed, the copper
metallochaperoneCOX17 speciﬁcally andphysically inter-
actswith SCO2 inorder todeliver copper toCOX.28 Further-
more, the p.R19H change in COX6B1 was recently shown
to be associated with the reduced stability of COX
holoenzyme and with severe early-onset leukodystrophic
encephalopathy, myopathy, and growth retardation.29 In
complementation assays, we observed a functional restora-
tion of COX upon the transfection of ﬁbroblasts from
patient II-4 with the wild-type cDNA. Moreover, yeast
Derv1/erv1R182H displayed a marked reduction in COX
activity. We can also speculate that mutated Erv1/GFER
might be less efﬁcient in shuttling electrons to oxidized
cytochrome c, from whence they ﬂow through COX to
molecular oxygen. In this pathway, the connection of the
disulﬁde relay with the respiratory chain would signiﬁ-
cantly decrease the efﬁciency of the oxidase activity.
Taken together, these data establish a role for the GFER
mutation in causing a moderate complex IV deﬁciency in
our affected individuals.602 The American Journal of Human Genetics 84, 594–604, May 15The intramitochondrial level of other DRS substrates, as
observed for TIMM13, may be equally affected by a defec-
tive Mia40-GFER system. The involvement of complexes I
and II among the respiratory-chain-deﬁcient activities
within the probands’ muscle suggests that other compo-
nents or assembly factors of these two complexes could
be less efﬁciently imported into the inner mitochondrial
compartment, perhaps through a TIM-dependent process.
The molecular dissection of these faulty mechanisms
remains to be elucidated.
Furthermore, both patients’ muscle and yeast Derv1//
erv1R182H displayed abnormal ultrastructural mitochondria
morphology andmtDNA instability. It is tempting to specu-
late that still uncharacterizedDRS-dependentproteins being
imported into the mitochondria with a lower efﬁciency
might cause the observed alteration of mitochondrial
morphology. Impairment of the connection between the
inner andoutermitochondrialmembranesmight also affect
the link to nucleoids, probably leading tomtDNAdisorgani-
zation and instability. Furthermore, the mtDNA abnor-
mality could be a consequence of a reduced interaction
between Erv1/GFER and cytochrome c. This interaction
directly connects the relay system to the respiratory chain
and prevents the generation of hydrogen peroxide, which, 2009
might perturb mtDNA stability. Although we consider the
small amount of muscle mtDNA deletions a secondary
consequence of a defective GFER-dependent mechanism, it
is noteworthy that, in S. cerevisiae, erv1p carrying p.F124S
leads to mtDNA depletion and impaired cell survival.26
Human GFER is also known as ALR (augmenter of liver
regeneration) or HPO (hepatopoietin), and it is thought to
be one of the factors responsible for the extraordinary
regenerative capacity of the mammalian liver.30 We did
not observe signs of hepatic involvement in patient II-4
on the abdominal ultrasound, althoughmarked hyperamy-
lasemia and hypoferritinemia, without any other apparent
cause, were found in all three probands. Except for the
congenital cataract, which has already been demonstrated
to be associated with some mitochondrial diseases,31 the
clinical phenotype and histological and biochemical
features described here were more prominent in the oldest
sibling, as was the presence of multiple mtDNA deletions.
These ﬁndings suggest a progressive course for the
pathology associated with the identiﬁed mutation.
Taken together, these results show a role for GFER in
causing an infantile disorder with combined respiratory-
chain deﬁciency, and they unravel the importance of the
DRS in the pathogenesis of humanmitochondrial diseases.
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